LCA0068

5-((E)-(3-fluorodibenzo[b,e]oxepin-11(6H)-ylidene)methyl)-1-((7R,8aR)-hexahydro-1H-pyrrolo[2,1-c][1,4]oxazin-7-yl)-1H-benzo[d]imidazol-2(3H)-one

LCA0069

5-(4-fluoro-2-(trifluoromethyl)phenyl)-1-((2R,3S)-3-hydroxybutan-2-yl)-4-methyl-N-(4-(methylsulfonyl)phenyl)-1H-pyrrole-3-carboxamide

LCA0070

5-(4-fluorophenyl)-1-((S)-3-hydroxy-3-methylbutan-2-yl)-N-((R)-1-(3-methyl-1,2,4-oxadiazol-5-yl)ethyl)-6-oxo-1,6-dihydropyridine-3-carboxamide

LCA0071

5-(4-methoxy-3-(tetrahydrofuran-3-yloxy)phenyl)-2-methylpyridazin-3(2H)-one

1093406-15-5

LCA0072

Desmethyl-VS-5584 5-(9-isopropyl-2-morpholino-9H-purin-6-yl)pyrimidin-2-amine

1246535-95-4

LCA0074

5,6-Dihydro-4H-1-thia-6-aza-benzo[e]azulene-2-carboxylic acid

153894-33-8

LCA0075

Vadimezan 5,6-Dimethylxantheonone-4-acetic acid

117570-53-3

LCA0076

NAV1.7-INHIBITOR 5-chloro-4-[(3,4-dichlorophenoxy)Methyl]-2-fluoro-N-(Methylsulfonyl)benzaMide

1355631-24-1

LCA0077

5F-UR-144 Prohibited/Forbidden Compounds

1364933-54-9

LCA0078

R306465 5-Pyrimidinecarboxamide, N-hydroxy-2-[4-(2-naphthalenylsulfonyl)-1-piperazinyl]- (9CI)

604769-01-9

LCA0079

6-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopropyl)nicotinic acid

153559-76-3

LCA0080

6-(1-(4-fluoro-2-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-5-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one

LCA0081

HPGDS-inhibitor-1 6-(3-fluorophenyl)-N-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)nicotinamide

1033836-12-2

LCA0082

CD437 6-(4-hydroxy-3-tricyclo(3.3.1.1(3,7))dec-1-ylphenyl)-2-naphthalenecarboxylic

125316-60-1

LCA0083

6,8-Bis(benzylthio)octanoic acid

95809-78-2

LCA0084

6-ECDCA Prohibited/Forbidden Compounds

459789-99-2

LCA0085

6-Thioguanine

154-42-7

LCA0086

7,10-Dihydro-8-nitro-7-oxo-1,10-phenanthroline-3-carboxylic acid

223664-42-4

LCA0088

A922500

959122-11-3

LCA0089

A66

1166227-08-2